Imunon Inc
IMNN
$1.66+4.40%
End of day · as of Aug 26, 2026, 1:58 AM ET
Mkt cap
$9.16M
EV/Sales
0.76
P/E ratio
N/A
FY2022 Revenue
$500,000
EPS (H1 2026)
$-1.38
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
-7179.65%
Beta
2.03
Div yield
N/A
Sector
Healthcare
Imunon Inc (IMNN) is a biotechnology company listed on US.
Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. Revenue was up 0.0% from 2021-12-31 to 2022-12-31. IMNN currently screens at market cap $9.2M.
Use this IMNN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IMNN income, balance, and cash tables.
Imunon Inc (IMNN) is a biotechnology company in the Healthcare sector.
Latest cached Imunon Inc (IMNN) revenue for Dec 31, 2022 was $500.0K. Net income was -$35.9M. Statements: https://lician.com/financials/imnn
Imunon Inc (IMNN) market capitalization is $9.2M on the latest cached snapshot.
Imunon Inc (IMNN) cached previous close $1.59; day range $1.60 – $1.70; volume 84,678. Session quote: https://lician.com/quote/imnn
Imunon Inc (IMNN) latest cached earnings event is "IMNN earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IMNN filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/imnn